Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotaka Watada

Showing results (71-80 of 515) with videos related to

Pageof 52
Sort By:
Journal of Diabetes Investigation|May 21, 2014
Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesKeiko Yamashiro, Fuki Ikeda, Yoshio Fujitani, et al.
Journal of Diabetes Investigation|December 26, 2024
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post-hoc analysis of imeglimin clinical trial dataJumpei Ito, Katsuhiko Hagi, Kenji Kochi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 31, 2022
Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in JapanYuya Nishida, Tomoya Mita, Makoto Hiki, et al.
Diabetes Care|April 17, 2020
Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical TrialHirotaka Watada, Akane Takami, Robert Spranger, et al.
Diabetology & Metabolic Syndrome|January 12, 2017
Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 studyHitoshi Ishii, Tetsuji Niiya, Yasuhiro Ono, et al.
Endocrine Journal|April 19, 2006
Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over studyShogo Kurebayashi, Hirotaka Watada, Yasushi Tanaka, et al.
Journal of Diabetes Investigation|May 21, 2014
Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiationMotoyuki Tamaki, Yoshio Fujitani, Toyoyoshi Uchida, et al.
Bioscience of Microbiota, Food and Health|July 20, 2022
Association of gut microbiota and inflammatory markers in obese patients with type 2 diabetes mellitus: post hoc analysis of a synbiotic interventional studyYukiko Sugawara, Akio Kanazawa, Masanori Aida, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension periodCaroline Reilhac, Julie Dubourg, Carole Thang, et al.
Biochemical and Biophysical Research Communications|April 5, 2016
Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscleShin-Ichi Ikeda, Yoshifumi Tamura, Saori Kakehi, et al.
Pageof 52

Showing results (71-80 of 515) with videos related to

Sort By:
Pageof 52
Journal of Diabetes Investigation|May 21, 2014
Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesKeiko Yamashiro, Fuki Ikeda, Yoshio Fujitani, et al.
Journal of Diabetes Investigation|December 26, 2024
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post-hoc analysis of imeglimin clinical trial dataJumpei Ito, Katsuhiko Hagi, Kenji Kochi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 31, 2022
Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in JapanYuya Nishida, Tomoya Mita, Makoto Hiki, et al.
Diabetes Care|April 17, 2020
Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical TrialHirotaka Watada, Akane Takami, Robert Spranger, et al.
Diabetology & Metabolic Syndrome|January 12, 2017
Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 studyHitoshi Ishii, Tetsuji Niiya, Yasuhiro Ono, et al.
Endocrine Journal|April 19, 2006
Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over studyShogo Kurebayashi, Hirotaka Watada, Yasushi Tanaka, et al.
Journal of Diabetes Investigation|May 21, 2014
Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiationMotoyuki Tamaki, Yoshio Fujitani, Toyoyoshi Uchida, et al.
Bioscience of Microbiota, Food and Health|July 20, 2022
Association of gut microbiota and inflammatory markers in obese patients with type 2 diabetes mellitus: post hoc analysis of a synbiotic interventional studyYukiko Sugawara, Akio Kanazawa, Masanori Aida, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension periodCaroline Reilhac, Julie Dubourg, Carole Thang, et al.
Biochemical and Biophysical Research Communications|April 5, 2016
Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscleShin-Ichi Ikeda, Yoshifumi Tamura, Saori Kakehi, et al.
Pageof 52